Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03839511 · ClinicalTrials.gov registry record
Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 4
- Enrollment target
NCT03839511: Completed study, sponsored by Pennington Biomedical Research Center.
NCT03839511 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03839511 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
A hyperinsulinemic-hypoglycemic clamp is an experimental procedure, which allows for hypoglycemia to be studied in a safe and controlled manner. The goal of this study is to establish the hyperinsulinemic-hypoglycemic clamp procedure at Pennington Biomedical Research Center in order to apply the knowledge gained to future studies which will determine the efficacy of our biomarker for predicting susceptibility to hypoglycemia. Additionally, our use of continuous glucose monitoring (CGM) during the clamp procedure will provide novel data regarding the accuracy of CGM during hypoglycemic conditions in a controlled research setting.
Primary Outcome
This value represents the average peak epinephrine value measured during the hypoglycemic clamp procedure
Interventions
- PROCEDURE Hyperinsulinemic-hypoglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-11-28 |
| Est. Completion | 2019-02-08 |
What the finished NCT03839511 record still lists
NCT03839511 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Hyperinsulinemic-hypoglycemic clamp is the first listed.
NCT03839511 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03839511 about?
NCT03839511 is a clinical study titled "Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study". A hyperinsulinemic-hypoglycemic clamp is an experimental procedure, which allows for hypoglycemia to be studied in a safe and controlled manner. The goal of this study is to establish the hyperinsulinemic-hypoglycemic clamp procedure at Pennington Biomedical Research Center in order to apply the kno...
What is the current status of trial NCT03839511?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2018-11-28. Estimated completion is 2019-02-08.
What interventions are being tested in trial NCT03839511?
The interventions under investigation include: Hyperinsulinemic-hypoglycemic clamp (PROCEDURE).
Who is sponsoring clinical trial NCT03839511?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI